Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Disc Medicine, Inc.

Report clinical trial data for bitopertin and DISC-0974

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
10 Aug 2022
Due
10 Aug 2023
Delivered
June 2023
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“We expect across the next 6-12 month to have readouts on bitopertin in the EPP trials and DISC-0974 in the two trials”

What we found

Evidence strength A What the grades mean

The company reported initial results for the bitopertin BEACON trial in June 2023 and had previously reported DISC-0974 Phase 1 results in June 2022, meeting the commitment within the 12-month timeframe.

  • A
    Disc Medicine, Inc. 10-Q filed 2023-08-11 Regulatory filing · published 11 Aug 2023 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint a571be08bad6
    “we announced top-line results from the Phase 1 DISC-0974 clinical trial in June 2022 and initial results from our Phase 2 BEACON clinical trial of bitopertin in June 2023.” ✓ confirmed on the page

Market reaction: the shares moved +4.8% against the S&P 500 over the three sessions around the disclosure (10 Aug 2023 to 15 Aug 2023). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
Clinical trial data readouts
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
Medium

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Partly met”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Disc Medicine, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-IRON-002116 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.